Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H. W. Jarrett
S87 Delivered Dose Intensity of Gemcitabine 1250 Mg/M2 With Cisplatin at 80 Mg/M2 (GC80) and 50 Mg/M2 (GC50) and Carboplatin AUC 6 (GCb6) in a Phase III Trial of Advanced Non-Small Cell Lung Cancer (NSCLC): Correlations With Clinical Outcomes
Thorax
Pulmonary
Respiratory Medicine
Related publications
Multiple Myeloma: Comparison of Two Dose-Intensive Melphalan Regimens (100 vs 200 Mg/M2)
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Osimertinib 160 Mg Daily for Advanced Non‐small Cell Lung Cancer With Leptomeningeal Metastasis: A Case Report
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
Fixed Dose Rate Versus Standard Dose Rate Infusion of Gemcitabine and Cisplatin in Advanced Stage Non-Small Cell Lung Cancer
Journal of Cancer Therapy
Randomized Phase II Trial of Paclitaxel and Carboplatin Followed by Gemcitabine Switch-Maintenance Therapy Versus Gemcitabine and Carboplatin Followed by Gemcitabine Continuation-Maintenance Therapy in Previously Untreated Advanced Non-Small Cell Lung Cancer
BMC Research Notes
Biochemistry
Medicine
Genetics
Molecular Biology
Triplet Chemotherapy Combination With Cisplatin, Gemcitabine and Docetaxel in Patients With Chemotherapy‑naive Advanced Non-Small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Survival Benefit of Intravenous Busulfan (120 Mg/M2) and Fludarabine Myeloablative Regimen for Treatment of Myeloid Malignancies
Journal of Stem Cell Research & Therapy
A Phase II Trial of Cremorphor EL-free Paclitaxel (Genexol-Pm) and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
A Phase I Trial of a Combination of Cisplatin and Carboplatin in Advanced Non-Small Cell Lung Cancer. An Intensification of Platinum Dose by a Combination of Two Platinum Cmpounds.
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
162P: Molecular Markers in Advanced Non Small Cell Lung Cancer Patients Receiving Gemcitabine & Cisplatin
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
